2024
CHEST Annual Meeting Insights
CHEST Insights 2024: The Promise of Biologics in COPD
FEATURING
James Krings
- 13 views
- November 20, 2024
CHEST Annual Meeting Insights
CHEST Insights 2024: Determining the Impact of COVID-19 Infection on People Hospitalized With COPD Exacerbations - A Nationwide Analysis
FEATURING
Antony Arumairaj
- 17 views
- November 13, 2024
CHEST Annual Meeting Insights
CHEST 2024 Insights: Vaccination Challenges and Strategies for Viral Respiratory Infections in Adults
FEATURING
Aanchal Kapoor
- 182 views
- November 11, 2024
CHEST Annual Meeting Insights
CHEST 2024 Insights: Pulmonary Hypertension in COPD - Exploring Treatment Options
FEATURING
Arun Jose
- 351 views
- November 10, 2024
- 3
CHEST Annual Meeting Insights
CHEST 2024 Insights: Management of Pulmonary Arterial Hypertension in the ICU: How to Keep the RV Happy
FEATURING
Jean Elwing
- 407 views
- November 7, 2024
- 5
CHEST Annual Meeting Insights
CHEST 2024 Insights: Immunotherapy From the Pulmonologist Point of View: Panacea or Poison?
FEATURING
Ajay Sheshadri
- 433 views
- November 4, 2024
- 7
CHEST Annual Meeting Insights
CHEST 2024 Insights: Exploring Duration Limits in VV ECMO for ARDS
FEATURING
Navitha Ramesh
- 195 views
- October 31, 2024
- 1
CHEST Annual Meeting Insights
CHEST 2024 Insights: BLVR Procedure Revisions to Optimize Outcomes
FEATURING
Jonathan Kurman
- 300 views
- October 30, 2024
- 3
CHEST Annual Meeting Insights
CHEST 2024 Insights: Efzofitimod for the Treatment of Pulmonary Sarcoidosis
FEATURING
Daniel Culver
- 511 views
- October 30, 2024
- 7
CHEST Annual Meeting Insights
CHEST 2024 Insights: Triple Inhaler Therapy in COPD - Bridging the Gap Between Evidence and Guidelines
FEATURING
Sara Assaf
- 662 views
- October 29, 2024
- 4
CHEST Annual Meeting Insights
CHEST 2024 Insights: The Efficacy of GLP1 Agonists and GIP/GLP1 Co-Agonists on Cardiovascular Outcomes in COPD Patients
FEATURING
Xin Ya See
- 232 views
- October 28, 2024
- 2
CHEST Annual Meeting Insights
CHEST 2024 Insights: Ensifentrine, a Novel COPD Treatment, Reduced COPD-Related Healthcare Resource Utilization Over 48 Weeks
FEATURING
Emily Wan
- 642 views
- October 25, 2024
- 6
CHEST Annual Meeting Insights
CHEST 2024 Insights: Barriers to Medications Used in Interstitial Lung Diseases and Solutions
FEATURING
Humayun Anjum
- 278 views
- October 23, 2024
- 2
CHEST Annual Meeting Insights
CHEST 2024 Insights: Leveraging AI to Facilitate Patient Screening and to Estimate the Prevalence of Pulmonary Hypertension Among Patients With COPD
FEATURING
Hilary M. Dubrock
- 109 views
- October 22, 2024
CHEST Annual Meeting Insights
CHEST 2024 Insights: Influence of Expedited Mechanical Thrombectomy on Outcomes in Acute Pulmonary Embolism: FLASH Registry Insights
FEATURING
Krunal Patel
- 384 views
- October 18, 2024
- 4
CHEST Annual Meeting Insights
CHEST 2024 Insights: Artificial Intelligence & Sepsis
FEATURING
Salim R Surani
- 276 views
- October 17, 2024
- 3
CHEST Annual Meeting Insights
CHEST 2024 Insights: Pulmonary Vascular Disease Highlights
FEATURING
Jean Elwing
- 13 views
- November 12, 2024
CHEST Annual Meeting Insights
CHEST 2024 Insights: Optimal Approach for Intermediate-High Risk PE
FEATURING
Howie Freeman
- 783 views
- October 15, 2024
- 10